Cooper Companies (NASDAQ:COO) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen upgraded shares of Cooper Companies (NASDAQ:COO) from a hold rating to a buy rating in a research note published on Saturday.

A number of other equities analysts have also recently commented on COO. JPMorgan Chase & Co. lifted their price objective on shares of Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a research report on Friday, December 5th. Barclays set a $98.00 target price on shares of Cooper Companies and gave the stock an “overweight” rating in a report on Monday, January 26th. Robert W. Baird upped their price target on shares of Cooper Companies from $85.00 to $98.00 and gave the company an “outperform” rating in a research note on Friday, December 5th. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, December 5th. Finally, Piper Sandler restated an “overweight” rating and set a $94.00 price objective (up from $83.00) on shares of Cooper Companies in a report on Friday, December 5th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $90.77.

Cooper Companies Trading Down 0.4%

Cooper Companies stock opened at $83.67 on Friday. Cooper Companies has a 52 week low of $61.78 and a 52 week high of $92.84. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.13 and a current ratio of 1.89. The stock has a market capitalization of $16.32 billion, a P/E ratio of 44.51, a PEG ratio of 2.39 and a beta of 1.03. The stock has a 50-day simple moving average of $82.27 and a 200 day simple moving average of $75.72.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.04. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The firm had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same quarter in the prior year, the company earned $1.04 earnings per share. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Analysts expect that Cooper Companies will post 3.98 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Holly R. Sheffield purchased 1,230 shares of the company’s stock in a transaction that occurred on Tuesday, December 16th. The stock was acquired at an average price of $80.75 per share, with a total value of $99,322.50. Following the completion of the purchase, the insider directly owned 39,052 shares in the company, valued at $3,153,449. This trade represents a 3.25% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Maria Rivas acquired 1,000 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The shares were purchased at an average cost of $82.13 per share, with a total value of $82,130.00. Following the transaction, the director directly owned 11,141 shares of the company’s stock, valued at $915,010.33. This trade represents a 9.86% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have purchased 16,014 shares of company stock valued at $1,304,416 in the last ninety days. Insiders own 1.98% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in COO. Vanguard Group Inc. boosted its holdings in shares of Cooper Companies by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 24,254,677 shares of the medical device company’s stock valued at $1,725,963,000 after purchasing an additional 421,423 shares in the last quarter. Capital World Investors lifted its position in shares of Cooper Companies by 25.7% during the 3rd quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock worth $723,417,000 after buying an additional 2,159,233 shares during the last quarter. State Street Corp boosted its stake in Cooper Companies by 2.4% in the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock valued at $720,736,000 after buying an additional 207,195 shares in the last quarter. Wellington Management Group LLP boosted its stake in Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after buying an additional 4,756,178 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in Cooper Companies by 58.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock valued at $494,123,000 after acquiring an additional 2,231,568 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.